1.      Amieva M, Peek RM Jr. Pathobiology of Helicobacter pyloriassociated gastric cancer. Gastroenterology 2016;150:64–78.

2.      Blecker U, Gold BD. Gastritis and peptic ulcer disease in childhood. Eur J Pediatr. 1999;158(7):541-546.

3.      Castellaneta SP, Afzal NA, Greenberg M, et al. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2004;39(3):257-261.

4.      Chen PH, Anderson L, Zhang K, et al. Eosinophilic gastritis/gastroenteritis. Curr Gastroenterol Rep. 2021;23(1):13.

5.      Colletti RB, Trainer TD. Collagenous gastritis. Gastroenterology. 1989;97(6):1552-1555.

6.      Dogan G, Duzgun F, Yilmaz O, Ayhan S, Gulen H, Kasirga E. A rare cause of ascites: eosinophilic gastroenteritis. J Pediatr Res. 2020;7(3):264-266.

7.      Dohil R, Hassall E, Jevon G, Dimmick J. Gastritis and gastropathy of childhood. J Pediatr Gastroenterol Nutr. 1999;29(4):378-394.

8.      Elitsur Y. Helicobacter-negative gastritis: the pediatric perspective. Am J Gastroenterol. 2013;108(7):1182-1183.

9.      Fossmark R, Sordal O, Jianu CS, et al. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Aliment Pharmacol Ther. 2012;36(11):1067-1075.

10.  Genta RM, Singhal A, Turner KO, et al. Lymphocytic gastritis and its relationships with other gastrointestinal disorders. Aliment Pharmacol Ther. 2021;54(10):1170-1178.

11.  Goncalves C, Oliveira ME, Palha AM, et al. Autoimmune gastritis presenting as iron deficiency anemia in childhood. World J Gastroenterol. 2014;20(42):15780-15786.

12.  Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology. 2008;134(2):491-499.

13.  Hayat M, Arora DS, Wyatt JI, et al. The pattern of involvement of the gastric mucosa in lymphocytic gastritis is predictive of the presence of duodenal pathology. J Clin Pathol. 1999;52(11):815-819.

14.  Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107(4):1673-1679.

15.  Hijaz NM, Septer SS, Degaetano J, et al. Clinical outcome of pediatric collagenous gastritis: case series and review of the literature. World J Gastroenterol. 2013;19(9):1478-1484.

16.  Homan M, Jones NL, Bontems P, et al. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr. 2024;79(3):758-785.

17.  Jevon GP, Dimmick JE, Dohil R, et al. Spectrum of gastritis in celiac disease in childhood. Pediatr Dev Pathol. 1999;2(3):221-226.

18.  Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents. J Pediatr Gastroenterol Nutr. 2017;64(6):991-1003.

19.  Kappi T, Wanders A, Wolving M, et al. Collagenous gastritis in children: incidence, disease course, and associations with autoimmunity and inflammatory markers. Clin Transl Gastroenterol. 2020;11(9):e00219.

20.  Ko HM, Morotti RA, Yershov O, et al. Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy. Am J Gastroenterol. 2014;109(8):1277-1285.

21.  Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53(2):230-243.

22.  Kong YJ, Yi HG, Dai JC, et al. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol. 2014;20(19):5903-5911.

23.  Kothari S, Elkhatib I. Eosinophilic enterocolitis with gastric outlet obstruction. ACG Case Rep J. 2020;7(12):e00344.

24.  Kulak O, Gurram B, Montgomery EA, et al. Pediatric autoimmune gastritis: clinical correlates and histologic features. Hum Pathol. 2021;116:31-38.

25.  Lee YJ, Lee M, Kim DJ, et al. Three case reports of collagenous gastritis in children: lessons for an endoscopic and histologic approach to mucosal nodularity of the stomach. Medicine (Baltimore). 2019;98(17):e14870.

26.  Lenti MV, Joudaki S, Miceli E, et al. Pediatric autoimmune gastritis: an international, multicentric study. J Pediatr Gastroenterol Nutr. 2025;81(5):1142-1150.

27.  Lenti MV, Rugge M, Lahner E, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6(1):56.

28.  Leung ST, Chandan VS, Murray JA, et al. Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol. 2009;33(5):788-798.

29.  Licari A, Votto M, D’Auria E, et al. Eosinophilic gastrointestinal diseases in children: a practical review. Curr Pediatr Rev. 2020;16(2):106-114.

30.  Mansoor E, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis: a population-based study in the United States. Clin Gastroenterol Hepatol. 2017;15(11):1733-1741.e1.

31.  Melo FF, Rocha AM, Rocha GA, et al. A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes Infect. 2012;14(4):341-347.

32.  Miguel N, Costa E, Santalha M Jr, et al. Refractory iron-deficiency anemia and autoimmune atrophic gastritis in the pediatric age group: analysis of 8 clinical cases. J Pediatr Hematol Oncol. 2014;36(2):134-139.

33.  Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis: pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529-541.

34.  Nordenstedt H, Graham DY, Kramer JR, et al. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013;108(1):65-71.

35.  Papadopoulou A, Amil-Dias J, Auth MK, et al. Joint ESPGHAN/NASPGHAN guidelines on childhood eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2024;78(1):122-152.

36.  Pinis, M., Ziv-Sokolovskaya, N., & Kori, M. Collagenous and lymphocytic gastritis in pediatric patients. A single-center experience observing an increase in diagnosis in recent years. Scandinavian Journal of Gastroenterology. 2024;59(10):1144–1150.

37.  Rustgi SD, Bijlani P, Shah SC. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Ther Adv Gastroenterol. 2021;14:17562848211038771.

38.  Shah SC, Piazuelo MB, Kuipers EJ, et al. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021;161(4):1325-1337.e7.

39.  Sharif F, McDermott M, Path MRC, et al. Focally enhanced gastritis in children with Crohn’s disease and ulcerative colitis. Am J Gastroenterol. 2002;97(6):1415-1420.

40.  Sipponen P, Price AB. The Sydney system for classification of gastritis 20 years ago. J Gastroenterol Hepatol. 2011;26(Suppl 1):31-34.

41.  Tozzoli R, Kodermaz G, Perosa AR, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10(2):80-83.

42.  Urganci N, Ozcelik G, Kalyoncu D, et al. Serum gastrin levels and gastroduodenal lesions in children with chronic renal failure on continuous ambulatory peritoneal dialysis: a single-center experience. Eur J Gastroenterol Hepatol. 2012;24(8):924-928.

43.  Ushiku T, Moran CJ, Lauwers GY. Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease. Am J Surg Pathol. 2013;37(12):1882-1888.